By transforming human scar cells into blood vessel cells, scientists at Houston Methodist may have discovered a new way to repair damaged tissue.
The method, described in an upcoming issue of Circulation (early online), appeared to improve blood flow, oxygenation, and nutrition to areas in need.
Cardiovascular scientists at Houston Methodist, with colleagues at Stanford University and Cincinnati Children’s Hospital, learned that fibroblasts — cells that causes scarring and are plentiful throughout the human body — can be coaxed into becoming endothelium, an entirely different type of adult cell that forms the lining of blood vessels.
“To our knowledge, this is the first time that trans-differentiation to a therapeutic cell type has been accomplished with a small molecules and proteins,” said Houston Methodist Research Institute Department of Cardiovascular Sciences Chair John Cooke, M.D., Ph.D., the study’s principal investigator. “In this particular case, we’ve found a way to turn fibroblasts into ‘shapeshifters’ nearly on command.”
Cooke said the regenerative medicine approach provides proof-of-concept for a small molecule therapy that could one day be used to improve the healing of cardiovascular damage or other injuries.
Other research groups have managed to generate endothelial cells cells using infectious virus particles specially engineered to deliver gene-manipulating DNA to cells. The DNA encodes proteins called transcription factors to alter gene expression patterns in such a way that cells behave more like endothelial cells.
“There are problems with using viruses to transfer genes into cells,” Cooke said. “This gene therapy approach is more complicated, and using viral vectors means the possibility of causing damage to the patient’s chromosomes. We believe a small-molecule approach to transforming the cells will be far more feasible and safer for clinical therapies.”
The Latest on: Reprogrammed cells
via Google News
The Latest on: Reprogrammed cells
- Myeloid Cells Hold Promise as Cancer Immunotherapy Targets, Review Sayson September 17, 2022 at 5:30 am
The review highlights current strategies for myeloid cell targeting and novel agents targeting myeloid cells for cancer treatment.
- New Israeli research could halt advancement of Parkinson’s Diseaseon September 16, 2022 at 3:49 am
The processes relate to the ability of cells to connect to the extracellular matrix and their capacity to create new synopses. Thanks to the use of the innovative Sendai Reprogramming technique ...
- Implanting a Patient’s Own Reprogrammed Stem Cells Shows Early Positive Results for Treating Dry AMDon September 15, 2022 at 9:00 pm
Researchers pursue experimental treatments for dry age-related macular degeneration that replace or replenish dead cells in the retina at the back of the eye.
- CapstanTx secures $165 million to deliver precise in vivo cell engineeringon September 15, 2022 at 2:43 am
Yesterday, the biotechnology company Capstan Therapeutics launched with $165 million in seed and Series A funding for it to build on its foundational insights into precision in vivo engineering ...
- Haifa U Identifies Nerve Cells’ Reduced Synaptic Activity Common to Parkinson’s Diseaseon September 12, 2022 at 6:21 am
The processes are related to the ability of cells to connect to the extracellular matrix and their capacity to create new synapses. Thanks to the use of the innovative Sendai Reprogramming ...
- Lyell Immunopharma Presents First in Human Trial Design of LYL797 at ESMO 2022on September 12, 2022 at 12:00 am
Lyell Immunopharma, Inc. (Nasdaq: LYEL), a clinical‑stage T-cell reprogramming company dedicated to developing curative cell therapies for patients with solid tumors, announced today that a poster ...
- Israeli researchers identify Parkinson's nerve cell processes for first time - studyon September 11, 2022 at 9:53 am
One of the problems in developing treatments is the fact that only 15% of Parkinson’s cases are caused by known genetic factors.
- Scientists Use CRISPR to Condense a Million Years of Evolution Into Mere Monthson September 11, 2022 at 7:00 am
Even with a wholesale shift in their genetics, mice reproduced and passed on their engineered quirks to a second generation of offspring.
via Bing News